A new Johns Hopkins study discovers an association between prenatal exposure to antidepressant medications, autism spectrum disorder (ASD), and developmental delays (DD) in boys.
Researchers from the Bloomberg School of Public Health found that early prenatal exposure to selective serotonin reuptake inhibitors (SSRIs) — commonly prescribed for depression, anxiety, and other disorders — increased the risk for ASD three-fold.
Common SSRIs include citalopram (Celexa), escitalopram (Lexapro), fluoxetine (Prozac), paroxetine (Paxil, Pexeva), and sertraline (Zoloft).
Full article: http://psychcentral.com/news/2014/04/16/1st-trimester-antidepressant-use-tied-to-autism-risk/68613.html